Exercise + Weight Loss Improves Asthma Control in Obese

Share this content:
Exercise + Weight Loss Improves Asthma Control in Obese
Exercise + Weight Loss Improves Asthma Control in Obese

FRIDAY, Jan. 6, 2017 (HealthDay News) -- For obese patients with asthma, adding exercise to a weight-loss program results in improved clinical control, according to a study published in the Jan. 1 issue of the American Journal of Respiratory and Critical Care Medicine.

Patricia D. Freitas, from the University of Sao Paulo in Brazil, and colleagues examined the impact of exercise training in a weight-loss program, which comprised nutrition and psychological therapies, on asthma control. Fifty-five obese patients with asthma were randomized to weight-loss program plus exercise (WL + E, 28 patients), which incorporated aerobic and resistance muscle training, or a weight-loss program plus sham (WL + S, 27 patients) that incorporated breathing and stretching exercises. Fifty-one patients were assessed after three months.

The researchers found that, compared with the WL + S group, the WL + E group had significantly improved clinical control scores (median, −0.7 versus − 0.3), greater weight loss (mean ± standard deviation, −6.8 ± 3.5 percent versus −3.1 ± 2.6 percent, respectively), and greater aerobic capacity (median, 3.0 versus 0.9 ml O2 × kg−1 × min−1). Improvements were also seen in lung function, anti-inflammatory biomarkers, and vitamin D levels in the WL + E group, as well as reductions in airway and systemic inflammation.

"Adding exercise to a short-term weight-loss program should be considered as a useful strategy for achieving clinical control of asthma in obese patients," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »